Explore more publications!

Trump ink executive order labels fentanyl as weapon of mass destruction

(MENAFN) The U.S. president on Monday signed an executive order officially classifying fentanyl as a “weapon of mass destruction,” elevating the drug crisis to the level of a major national security concern.

According to official statements, the order was signed during a White House ceremony recognizing members of the U.S. military involved in border security missions. During the event, the president emphasized the severe danger posed by fentanyl, describing it as a lethal force affecting communities across the country.

“No bomb does what this is doing,” Trump said, arguing that the scale of fatalities linked to the drug is unprecedented. He further stated that “200,000 to 300,000 people die each year.”

The president also used the occasion to highlight what he described as dramatic improvements in border enforcement, saying, “We took the worst border in the history of our country, and in a period of two months, we turned it into the strongest border in the history of our country.”

According to reports, the executive order is intended to frame fentanyl trafficking not only as a criminal issue but also as a strategic threat requiring heightened federal response.

MENAFN16122025000045017640ID1110485349


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions